TTP is driven by a marked deficiency of ADAMTS-13 activity to <10% by either an acquired autoimmune phenomenon or by inherited mutations to the ADAMTS13 gene in combination with an additional trigger [7,57]. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.